Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Optinose Inc (OPTN)

Optinose Inc (OPTN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Optinose Inc 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 USA

P: 267-364-3500 F: 267-395-2119

Description:

OptiNose Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of products for patients treated by ear, nose and throat or ENT and allergy specialists. The company's lead product consists of XHANCE nasal polyps, XHANCE Chronic sinusitis, OPN-300, OPN- 021 and AVP-825 which are in clinical stage. OptiNose Inc. is headquartered in Pennsylvania, USA.

Key Statistics

Overview:

Market Capitalization, $K 158,328
Shares Outstanding, K 53,309
Annual Sales, $ 49,120 K
Annual Net Income, $ -99,790 K
Last Quarter Sales, $ 18,360 K
Last Quarter Net Income, $ -23,500 K
60-Month Beta 0.99
% of Insider Shareholders 6.00%
% of Institutional Shareholders 42.51%
Float, K 50,110
% Float 94.00%

Growth:

1-Year Return -21.43%
3-Year Return -76.11%
5-Year Return 0.00%
5-Year Revenue Growth 61,300.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/17/21
Earnings Per Share ttm -1.82
EPS Growth vs. Prev Qtr 10.20%
EPS Growth vs. Prev Year 21.43%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

OPTN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -3.92
Price/Earnings to Growth N/A
Return-on-Equity % -1,275.55%
Return-on-Assets % -56.73%
Profit Margin % -203.16
Net Margin % N/A
Debt/Equity N/A
Price/Sales 3.20
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.70
Interest Coverage -6.67
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar